Details for New Drug Application (NDA): 020453
✉ Email this page to a colleague
The generic ingredient in PANDEL is hydrocortisone probutate. There are sixty-seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the hydrocortisone probutate profile page.
Summary for 020453
Tradename: | PANDEL |
Applicant: | Ani Pharms |
Ingredient: | hydrocortisone probutate |
Patents: | 0 |
Pharmacology for NDA: 020453
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Suppliers and Packaging for NDA: 020453
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PANDEL | hydrocortisone probutate | CREAM;TOPICAL | 020453 | NDA | ANI Pharmaceuticals, Inc. | 62559-325 | 62559-325-26 | 6 TUBE in 1 CARTON (62559-325-26) / 2 g in 1 TUBE |
PANDEL | hydrocortisone probutate | CREAM;TOPICAL | 020453 | NDA | ANI Pharmaceuticals, Inc. | 62559-325 | 62559-325-80 | 1 TUBE in 1 CARTON (62559-325-80) / 80 g in 1 TUBE |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM;TOPICAL | Strength | 0.1% | ||||
Approval Date: | Feb 28, 1997 | TE: | RLD: | Yes |
Expired US Patents for NDA 020453
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ani Pharms | PANDEL | hydrocortisone probutate | CREAM;TOPICAL | 020453-001 | Feb 28, 1997 | 4,794,106 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription